Start collaboration with an online pharmacy that connects to medication management after online consultations.

New features added to the hay fever support app "AllerSearch+ (Plus)"

Exhibiting at healthTECH Japan 2025 (BioJapan / Regenerative Medicine JAPAN concurrently held)

Obtained CRB approval for a multicenter specific clinical study regarding the effects of an unapproved medical device program for pediatric amblyopia training using VR.

Exhibiting next-generation vision care solutions at the 58th Japanese Ocular Inflammation Society (Foursome 2025)

[Osaka-Kansai Expo] Presented on the theme of the future of ophthalmic medicine.

A paper on the safety of an unapproved VR-based software medical device for pediatric amblyopia training in healthy adults has been published in JMIR Formative Research.

Join the Startup Association (General Incorporated Association)

Won an award in the Hiyocorn Division at the "Tokyo Venture Company Championship 2024".

Booth exhibition at GATEWAY Tech TAKANAWA 2025, held at TAKANAWA GATE CITY on Tue, 5/13 and Wed, 5/14.

Selected for the FY2024 "New Business Creation Support Project for Older Adults"

Selected for the "TOKYO Strategic Innovation Promotion Program" implemented by the Tokyo Metropolitan Government and the Tokyo Metropolitan Small and Medium Enterprise Promotion Corporation (Public Interest Incorporated Foundation).

Introducing a new way to combat hay fever! Free download of the smartphone app "AllerSearch+" now available.

The app “AllerSearch+,” which supports daily hay fever management, will be released at the end of January 2025.

Selected for the FY2024 Startup Intellectual Property Support Program Hands-on Support

Exhibiting at the MWC Barcelona "JAPAN Pavilion"

Recognized as a full member of the Japan Ophthalmic Medical Device Association

for the FY2024 ICT Startup League

Selected for the Japan Agency for Medical Research and Development (AMED) FY2024 “Medical-Engineering Collaboration Innovation Promotion Program (Development and Commercialization Program [Venture Development])”

Received the Innovation Award at the final pitch of AMED’s Startup Problem-Solving Support Program for Young Researchers for developing a VR-based software medical device for pediatric amblyopia training.

Raised funding from Rohto Pharmaceutical Co., Ltd. in Series B. Total funding has reached 720 million yen.

Selected for the "Overseas Expansion Support Program" of "NEXs Tokyo," a startup support initiative organized by the Tokyo Metropolitan Government.

Selected for Juntendo University AI Incubation Farm MedTec Startup Acceleration Program "JASTAR".

Coworking Members Selected for the Silicon Valley Startup Support Hub

We have issued a press release on the validation of the equivalence of patient-reported outcomes collected through a dry eye disease-specific questionnaire implemented in a smartphone app.

Selected as a participating institution for the Japan Agency for Medical Research and Development (AMED) FY2023 “Startup Problem-Solving Support Program by Young Researchers.”

Raised ¥220 million in seed and Series A funding rounds.

We have issued a press release announcing the start of a multicenter specified clinical study aimed at developing and obtaining approval for a smartphone app-based software medical device that supports dry eye diagnosis using smartphones.

We were selected as a certified company for the 7th J-TECH STARTUP SUMMIT, hosted by TEP, a startup support organization, which recognizes startups expected to achieve global growth through businesses that make technology their core competence.

We have obtained a Type II medical device manufacturing and marketing business license.

Received the Healthcare Innovation Challenge Award at the final judging of the 4th Healthcare Venture Grand Prize.

We have issued a press release regarding the start of research and development of a VR app for pediatric amblyopia treatment.

Juntendo University has issued a press release on the verification of the reliability and validity of dry eye diagnostic support using "DryEyeRhythm®".

We issued a press release regarding the launch of Corona Pass, an app that displays negative test certificates for COVID-19 medical antigen test kits.